Jyong Biotech Ltd. - Ordinary shares (NQ:MENS)
15.02
-7.37
(-32.92%)
Streaming Delayed Price
Updated: 3:22 PM EST, Dec 16, 2025
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 333,139 |
| Open | 23.00 |
| Bid (Size) | 14.72 (100) |
| Ask (Size) | 15.39 (200) |
| Prev. Close | 22.39 |
| Today's Range | 13.36 - 23.00 |
| 52wk Range | 7.060 - 67.00 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
12 Health Care Stocks Moving In Friday's After-Market Session ↗
October 31, 2025
Top stock movements in today's session. ↗
October 28, 2025
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
October 28, 2025
Trump Sparks A 2025 IPO Boom: 5 New Stocks Have Rallied Over 400% ↗
October 07, 2025
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
October 01, 2025
12 Health Care Stocks Moving In Monday's Intraday Session ↗
September 22, 2025
12 Health Care Stocks Moving In Monday's Intraday Session ↗
August 11, 2025
Frequently Asked Questions
Is Jyong Biotech Ltd. - Ordinary shares publicly traded?
Yes, Jyong Biotech Ltd. - Ordinary shares is publicly traded.
What exchange does Jyong Biotech Ltd. - Ordinary shares trade on?
Jyong Biotech Ltd. - Ordinary shares trades on the Nasdaq Stock Market
What is the ticker symbol for Jyong Biotech Ltd. - Ordinary shares?
The ticker symbol for Jyong Biotech Ltd. - Ordinary shares is MENS on the Nasdaq Stock Market
What is the current price of Jyong Biotech Ltd. - Ordinary shares?
The current price of Jyong Biotech Ltd. - Ordinary shares is 15.02
When was Jyong Biotech Ltd. - Ordinary shares last traded?
The last trade of Jyong Biotech Ltd. - Ordinary shares was at 12/16/25 03:22 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.